Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence

Min Deng,Shuang Wu,Peizheng Huang,Yun Liu,Chong Li,Ji Zheng
DOI: https://doi.org/10.1016/j.ajps.2023.100870
IF: 9.273
2023-12-01
Asian Journal of Pharmaceutical Sciences
Abstract:Metastasis-associated processes are the predominant instigator of fatalities linked to cancer, wherein the pivotal role of circulating tumor cells lies in the resurgence of malignant growth. In recent epochs, exosomes, constituents of the extracellular vesicle cohort, have garnered attention within the field of tumor theranostics owing to their inherent attributes encompassing biocompatibility, modifiability, payload capacity, stability, and therapeutic suitability. Nonetheless, the rudimentary functionalities and limited efficacy of unmodified exosomes curtail their prospective utility. In an effort to surmount these shortcomings, intricate methodologies amalgamating nanotechnology with genetic manipulation, chemotherapy, immunotherapy, and optical intervention present themselves as enhanced avenues to surveil and intercede in tumor metastasis and relapse. This review delves into the manifold techniques currently employed to engineer exosomes, with a specific focus on elucidating the interplay between exosomes and the metastatic cascade, alongside the implementation of tailored exosomes in abating tumor metastasis and recurrence. This review not only advances comprehension of the evolving landscape within this domain but also steers the trajectory of forthcoming investigations. Graphical abstract Engineered exosomes prepared by top-down, bottom-up, and hybrid strategies can be an enhanced approach to monitor and intervene in tumor metastasis and recurrence through a complex approach combining nanotechnology with gene therapy, chemotherapy, immunotherapy, and optical therapy. Download : Download high-res image (438KB) Download : Download full-size image
pharmacology & pharmacy
What problem does this paper attempt to address?